AJANTPHARM - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.2
Show all parameters (20 more)
🧾 Trade Setup
Buy Price: 3,560 ₹. Initial Stop Loss: 3,510 ₹. Target 1: 3,620 ₹ (based on current momentum), Target 2: 3,700₹ if volume continues to support the rise. Maintain strict stop-loss discipline – a breach of 3,510₹ necessitates immediate exit. This is a moderate opportunity with clear risk and reward.
✅ Positive
Strong Qtr Profit growth (23.7%) and a significant increase in PAT compared to the previous quarter provides momentum. High volume of 210k shares traded indicates strong interest today.
⚠️ Limitation
The high P/E ratio of 44.2, significantly elevated above the industry average of 34.8, suggests potential overvaluation – particularly considering the PEG Ratio of 2.22. This could be susceptible to a correction if growth expectations aren’t fully priced in or if broader market sentiment shifts.
📈 Company Positive News
The recent share price rise of 2.04% is encouraging, and analyst reports highlighting the stock's valuation and sector performance add further positive momentum.
🏭 Industry
The pharmaceutical sector remains relatively stable with overall positive investor interest driven by innovation and increasing healthcare spending in India. However, broader market volatility could impact individual stock performance today.